Predictors of Recurrence for High Risk Endometrial Cancer Patients
This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.
High-risk Endometrial Cancer
DRUG: adjuvant therapy
Factors affecting overall survival, Factors affecting overall survival, 10 years
Factors affecting progression-free survival, Factors affecting progression-free survival, 10 years
The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high.The investigators retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.